Johnson Controls Internation

Johnson & Johnson stock declined 0.6% in after-hours trading Monday as healthcare stocks underperformed the broader market. The company faces ongoing talc litigation and will present at an industry conference next month.

Johnson & Johnson stock declined 1.1% as healthcare stocks underperformed the broader market. Traders are eyeing upcoming U.S. jobs and inflation data for direction.

Johnson & Johnson shares approached a 52-week high as a New Jersey court disqualified a plaintiffs' firm from talc cases and the company reported positive pilot data for its atrial fibrillation platform.